Theravance, Mylan To Offer Added Phase 3 Data For TD-4208 At CHEST: 'Presentations Highlight 24-Hour Serial Spirometry Subgroup Findings from 2 Replicate Pivotal Phase 3 Studies; Improvements Observed in St. George's Respiratory Questionnaire...'